Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eszter Lazar-Molnar

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 24, 2014
Autoimmune NMDA receptor encephalitisEszter Lazar-Molnar, Anne E Tebo
Cellular Immunology|May 1, 2007
The interchain disulfide linkage is not a prerequisite but enhances CD28 costimulatory functionEszter Lazar-Molnar, Steven C Almo, Stanley G Nathenson
Trends in Molecular Medicine|December 3, 2014
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathwayKim C Ohaegbulam, Amer Assal, Eszter Lazar-Molnar, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Comparison of Clinical Laboratory Assays for Measuring Serum Infliximab and Antibodies to InfliximabMaria Alice V Willrich, Eszter Lazar-Molnar, Melissa R Snyder, et al.
Clinical Chemistry|September 12, 2020
Development of Label-Free Immunoassays as Novel Solutions for the Measurement of Monoclonal Antibody Drugs and Antidrug AntibodiesYiqi Ruben Luo, Indrani Chakraborty, Eszter Lazar-Molnar, et al.
Eukaryotic Cell|May 20, 2008
A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophagesLi Shi, Priscila C Albuquerque, Eszter Lazar-Molnar, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 13, 2018
Development and validation of a targeted affinity-enrichment and LC-MS/MS proteomics approach for the therapeutic monitoring of adalimumabYifei Yang, Emily Wysocki, Kwasi Antwi, et al.
Renal Failure|January 25, 2026
Early posttransplant rituximab use in kidney transplant recipients with preexisting donor-specific antibodiesJunji Yamauchi, Katalin Fornadi, Divya Raghavan, et al.
Immunological Reviews|May 12, 2009
Sequence, structure, function, immunity: structural genomics of costimulationKausik Chattopadhyay, Eszter Lazar-Molnar, Qingrong Yan, et al.
Kidney International Reports|January 15, 2025
<i>De novo</i> Membranous Nephropathy in Renal Allografts is Associated With Protocadherin FAT1Laith F Al-Rabadi, Aaron Storey, Christopher P Larsen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 24, 2014
Autoimmune NMDA receptor encephalitisEszter Lazar-Molnar, Anne E Tebo
Cellular Immunology|May 1, 2007
The interchain disulfide linkage is not a prerequisite but enhances CD28 costimulatory functionEszter Lazar-Molnar, Steven C Almo, Stanley G Nathenson
Trends in Molecular Medicine|December 3, 2014
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathwayKim C Ohaegbulam, Amer Assal, Eszter Lazar-Molnar, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Comparison of Clinical Laboratory Assays for Measuring Serum Infliximab and Antibodies to InfliximabMaria Alice V Willrich, Eszter Lazar-Molnar, Melissa R Snyder, et al.
Clinical Chemistry|September 12, 2020
Development of Label-Free Immunoassays as Novel Solutions for the Measurement of Monoclonal Antibody Drugs and Antidrug AntibodiesYiqi Ruben Luo, Indrani Chakraborty, Eszter Lazar-Molnar, et al.
Eukaryotic Cell|May 20, 2008
A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophagesLi Shi, Priscila C Albuquerque, Eszter Lazar-Molnar, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 13, 2018
Development and validation of a targeted affinity-enrichment and LC-MS/MS proteomics approach for the therapeutic monitoring of adalimumabYifei Yang, Emily Wysocki, Kwasi Antwi, et al.
Renal Failure|January 25, 2026
Early posttransplant rituximab use in kidney transplant recipients with preexisting donor-specific antibodiesJunji Yamauchi, Katalin Fornadi, Divya Raghavan, et al.
Immunological Reviews|May 12, 2009
Sequence, structure, function, immunity: structural genomics of costimulationKausik Chattopadhyay, Eszter Lazar-Molnar, Qingrong Yan, et al.
Kidney International Reports|January 15, 2025
<i>De novo</i> Membranous Nephropathy in Renal Allografts is Associated With Protocadherin FAT1Laith F Al-Rabadi, Aaron Storey, Christopher P Larsen, et al.
Pageof 2